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Here we review available data on nitric oxide (NO)-mediated signaling in skeletal muscle
during physical exercise. Nitric oxide modulates skeletal myocyte function, hormone
regulation, and local microcirculation. Nitric oxide underlies the therapeutic effects of
physical activity whereas the pharmacological modulators of NO-mediated signaling are
the promising therapeutic agents in different diseases. Nitric oxide production increases
in skeletal muscle in response to physical activity. This molecule can alter energy
supply in skeletal muscle through hormonal modulation. Mitochondria in skeletal muscle
tissue are highly abundant and play a pivotal role in metabolism. Considering NO a
plausible regulator of mitochondrial biogenesis that directly affects cellular respiration, we
discuss the mechanisms of NO-induced mitochondrial biogenesis in the skeletal muscle
cells. We also review available data on myokines, the molecules that are expressed
and released by the muscle fibers and exert autocrine, paracrine and/or endocrine
effects. The article suggests the presence of putative interplay between NO-mediated
signaling and myokines in skeletal muscle. Data demonstrate an important role of NO in
various diseases and suggest that physical training may improve health of patients with
diabetes, chronic heart failure, and even degenerative muscle diseases. We conclude
that NO-associated signaling represents a promising target for the treatment of various
diseases and for the achievement of better athletic performance.
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Introduction
Nitric oxide (NO) was first discovered as a marker of inflammation and a regulator of vascular
tone. However, the following studies demonstrated that spectrum of the regulatory functions of
this molecule is much broader. Indeed, NO production changes in response to various stimuli in
health and disease.
One of the intriguing facts is an increase in NO production in skeletal muscle in response
to physical exercise. Previously, the role of NO in skeletal muscle was discussed in a com-
prehensive review written by Stamler and Meissner (2001). A brief review of this subject was
published by Reid (1998) with emphasis on synthesis, distribution and functional importance
of NO in skeletal muscle. Maréchal and Gailly divided the effects of NO in skeletal mus-
cle into two groups, namely: direct and cGMP-mediated effects (Maréchal and Gailly, 1999).
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Kingwell discussed NO-mediated metabolic regulation during
exercise in health and disease (Kingwell, 2000a) including car-
diovascular pathologies (Kingwell, 2000a). Bredt (1999) and
Kingwell (2000b) presented a literature review covering a wide
range of questions regarding the NO effects on the organism.
Kaminski and Andrade (2001) also reviewed NO-mediated bio-
logical effects on the muscle and their role in muscle disease.
The subject of NO production in physical exercise has been
of interest for many years; new studies brought more clarity to
the overall picture of the role of NO. However, some aspects
of this research area remain controversial. Indeed, the results of
some studies suggest that eNOS and nNOS are not critical for
the exercise-induced augmentation of mitochondrial biogenesis
in skeletal muscle (Wadley et al., 2007) whereas other studies
provide evidence that exercise and mitochondrial biogenesis are
associated with NO-dependent changes in AMPK and PGC-1α
(Lira et al., 2010).
The present review focuses on recent data and highlights
the latest advances in studying the intrinsic interplay between
NO and physical exercise. The manuscript reviews NO-mediated
effects on skeletal myocytes, hormone regulation, and local
microcirculation. The authors discuss NO-dependent signaling
pathways and significance of the exercise-induced NO produc-
tion in health and disease.
Nitric Oxide Synthases (NOS) in Skeletal Muscle
Nitric oxide is generated from amino acid L-arginine by NOS
(Moncada and Higgs, 1993). The second significant source of
NO refers to its bound forms. According to estimates, 70–90%
of NO is stored in S-nitrosothiols, main source of NO in tissues
(Nijkamp and Folkerts, 1995).
Three isoforms of NOS have been identified: an endothe-
lial isoform (eNOS; gene located on chromosome 7), a neu-
ronal isoform (nNOS; gene located on chromosome 12) and a
macrophage or inducible isoform (iNOS; gene located on chro-
mosome 17). eNOS and nNOS are the normal constituents
of healthy cells. They both contribute to physiological regula-
tion (Lugg et al., 1995). By using immunocytochemical meth-
ods, Kobzik et al., demonstrated that nNOS (Kobzik et al.,
1994) and eNOS (Kobzik et al., 1995) are expressed in skele-
tal muscle. Moderate exercise increases activity of the entire
NOS pool (i.e., the cumulative activity of eNOS, nNOS, and
iNOS). Electrical stimulation of skeletal muscular cells is asso-
ciated with the increased iNOS content, NO production, and
NF-kB activation (Lambertucci et al., 2012). A single moder-
ate exercise increases NO content through an activation of
nuclear factor kappa B (da Silva Rossato et al., 2014). nNOS
expression is significantly higher in mice deficient for eNOS
gene (eNOS−/−) (Wadley et al., 2007). In mature skeletal and
cardiac myocytes, nNOS contains a 34-amino-acid insert as a
result of the alternative splicing of nNOS pre-RNA between
exons 16 and 17 (Brenman et al., 1997). A skeletal muscle-specific
nNOS is identified as a component of dystrophin complex
(Chao et al., 1998).
There are three different fractions of nNOS: nNOSβ
of Golgi apparatus, sarcolemmal nNOSµ, and cytoplasmic
nNOSµ (Silvagno et al., 1996; Percival et al., 2010). To determine
the location of cytoplasmic nNOS, Percival et al. immunolabeled
single muscle fibers. Four pan-specific anti-nNOS antibodies
raised against distinct epitopes detected that nNOS localize to
sub-sarcolemmal puncta. The labeling pattern resembled that
of the skeletal muscle Golgi complex. Moreover, nNOS colocal-
izes with GM130, a marker of the cis-face of the Golgi com-
plex suggesting the existence of a previously unrecognized Golgi-
associated nNOS compartment in the skeletal muscle cells. Evi-
dence suggests that (i) loss of signaling from nNOSµ does not
limit force production during or after exercise; (ii) nNOSβ is a
critical regulator of skeletal muscle fatigue and postexercise force
output; (iii) during exercise, nNOSµ signaling maintains blood
delivery to the muscle, while nNOSβ regulates fatigue resistance
of the muscle and postexercise force output; and (iv) the dif-
ferential targeting of nNOS splice variants creates functionally
distinct NO signaling microdomains, at which NOS-derived NO
acts locally (Percival et al., 2010). The nNOS splice variant, local-
ized to the Golgi complex, regulates microtubule cytoskeleton
integrity in skeletal muscle (Percival et al., 2010). Sarcolemmal
nNOSµ affects muscle ability to absorb oxygen and is recruited
to the sarcolemma by binding to the dystrophin-associated pro-
tein α-syntrophin (Thomas et al., 2003). nNOSµ is responsible
for maintaining blood supply during physical exercise, glucose
homeostasis modulation, muscular mass control, and regulation
of the fatigue resistance (Percival et al., 2010). Intense exercise
that lasts for 10 days is sufficient to uniformly increase nNOSµ
expression in untrained individuals (McConell et al., 2007).
Reactive Oxygen Species Limit Nitric Oxide
Signaling
Data suggest that NO content is decreased in the exhaled air
from the volunteers after running on a treadmill at altitudes of
2800 and 180m for several minutes. Partial pressure of NO sig-
nificantly decreases at both altitudes (Stang et al., 2014). What
are the factors limiting NO signaling? The bioavailability of
NO depends on the balance between the enzymatic and non-
enzymatic NO production and NO removal due to interactions
between NO and reactive oxygen species (ROS). The presence
of the latter depends on ROS formation by NADPH and xan-
thine oxidases in mitochondria. It also depends on ROS removal
by antioxidant defense systems (Reutov and Sorokina, 1998;
Reutov, 1999). When NO is produced enzymatically, L-arginine
serves as a substrate for NOS (Moncada and Higgs, 1993). The
second significant source of NO is associated with its bound
forms. Cells generate NO from nitrates and nitrites either non-
enzymatically or enzymatically by NO−3 and NO
−
2 reductases
(Cantu-Medellin and Kelley, 2013) Some estimates suggest that
70–90% of NO is generated from S-nitrosothiols, main source
of NO in tissues (Nijkamp and Folkerts, 1995). Nitric oxide
exerts its regulatory effects through several mechanisms. The first
mechanism consists in the S-nitrosylation where NO binds to
the mixed-valence metals in metalloproteins, SH-groups in cys-
teine, and to tyrosine. Nitrosylation of proteins changes their
biological properties and functions (Broillet, 1999; Feng, 2012).
Other mechanisms are associated with NO-induced guanylate
cyclase activation, cGMP increase, calcium signaling modifica-
tion, and reverse protein phosphorylation (Maréchal and Gailly,
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1999; Moyna and Thompson, 2004; Tschakovsky and Joyner,
2008).
Excess of ROS both reduces NO bioavailability and damages
cells of the cardiovascular system. Physical activity significantly
improves cardiovascular function, in particular, through the
increased bioavailability of NO, enhanced endogenous antiox-
idant protection, and the reduced expression of ROS-forming
enzymes (Gliemann et al., 2014). Besides, there are data that
superoxide can directly suppress NOwithout affecting expression
or activity of eNOS (Paolocci et al., 2001).
Effects of NO Modulators on Skeletal Muscle
Performance
Hemodynamic reserve largely limits physical performance. Nitric
oxide can control the local hemodynamics in dependence on
physical effort at the level of an individual muscular group. In
this regard, the effects of NO donors on physical performance are
of great interest.
Administration of L-arginine to healthy volunteers does
not significantly change metabolic and hormonal parameters
compared with the effects of physical exercise (Alvares et al.,
2014). However, intake of L-arginine increases muscle strength
(Alvares et al., 2014) and recovery after physical exercise
(Santos et al., 2002). Indeed, single administration of L-arginine
in healthy individuals before strength exercise increases the vol-
ume of blood in the muscle. It is interesting that no signifi-
cant difference in plasma concentrations of nitrites after acute
administration of L-arginine alone or in response to resistance
exercise is reported (Alvares et al., 2012a,b). Beneficial effects of
L-arginine are explained by dilation of blood vessels in response
to NO increase.
Infusion of a non-specific NO synthase inhibitor, L-NMMA,
significantly reduces glucose uptake in the leg due solely to
a decrease in an arteriovenous glucose difference, as there is
no effect of L-NMMA infusion on local blood flow during
exercise. These data may suggest that NO production con-
tributes substantially to an exercise-mediated skeletal muscle glu-
cose uptake in humans independently of skeletal muscle blood
flow (Bradley et al., 1999). L-arginine infusion during exercise
also significantly increases skeletal muscle glucose clearance in
humans. Because plasma insulin concentration is unaffected by
L-arginine infusion, greater NO production may be responsi-
ble for this effect (McConell et al., 2006). Phosphodiesterase
inhibitor, EMD360527, causes an increase in vasodilation in sys-
temic and pulmonary circulation at rest and during treadmill
exercise in pigs (Zhou et al., 2014a,b). Therefore, pharmacolog-
ical support targeting NO-mediated signaling may be promising
for improving athletic performance.
Nitric Oxide Affects Hormone Regulation in
Skeletal Muscle
Large body of evidence suggests that effects of NO are not limited
by its impact on regional hemodynamics and microcirculation
(Del Pozzi et al., 2013). Nitric oxide can alter energy supply in
skeletal muscles through the modulation of hormones target-
ing skeletal muscle. Indeed, NO stimulates production of human
growth hormone (GH) in cultured fetal pituitaries and GH-
secreting adenomas (Rubinek et al., 2005). There is a hypothe-
sis that L-arginine improves exercise performance by increasing
NO production and the levels of insulin and growth hormone
(GH). However, 4-week L-arginine supplementation does not
affect metabolic and hormonal parameters beyond those changes
achieved with the exercise alone (Campbell et al., 2006; Alvares
et al., 2014). eNOS heterozygous mice have lower glucose lev-
els during exercise compared with the wild-type mice whereas
eNOS knockout mice demonstrate lower levels of glucose than
the eNOS heterozygous mice and become hypoglycemic after the
exercise (Lee-Young et al., 2010). These data suggest that eNOS
is involved in the regulation of glucose metabolism in physical
exercise. These NO effects are mediated through the changes in
the insulin production. Quantitative reduction in eNOS protein
expression can result in metabolic dysregulation in vivo. On the
other hand, hormones can affect NOS. For example, treatment
of cultured human endothelial cells with somatotropin results in
significant increase in the eNOS gene and protein expression and
NO release whereas production of intracellular ROS is signifi-
cantly reduced in the presence of somatotropin. Enhanced eNOS
gene/protein expression correlates well with the enzyme activity
(Thum et al., 2003). It is important, that vascular and hormonal
mechanisms of NO effects on the skeletal muscular contractions
cannot be studied separately from each other.
Direct Effects of NO on Skeletal Myocytes
Nitric oxide indirectly modulates supply of the skeletal myocytes
with oxygen and energy substrates via the regulation of blood
flow and hormones (Santos et al., 2002; Alvares et al., 2012a,
2014). However, there is evidence that NO can directly affect
skeletal muscle through the modulation of energy metabolism.
In general, the effects of NO are mediated through cGMP that, in
turn, is metabolized by phosphodiesterases. An inhibitor of phos-
phodiesterase 5, sildenafil, increases protein synthesis, changes
protein expression and nitrosylation, and decreases fatigability of
human skeletal muscle (Sheffield-Moore et al., 2013). In knock-
out mouse model, eNOS affects the ATP levels. Basal ATP levels
are distinct in skeletal muscles in mice with wild-type (WT), par-
tial expression (±), or no expression (-/-) of eNOS. Uptakes of
glucose and long-chain fatty acid as well as glycogenolysis during
exercise are markedly accelerated in liver tissue and skeletal mus-
cle in the eNOS−/− mice compared with eNOS± and WT mice
(Lee-Young et al., 2010).
Nitric Oxide and Mitochondria
In skeletal muscle, mitochondria are highly abundant and
play a pivotal role in metabolism (Hood et al., 2006). Nitric
oxide is a plausible regulator of mitochondrial biogenesis
and can directly affect respiration in myocytes. nNOSβ iso-
form, associated with Golgi apparatus, affects mitochondrial
function. Indeed, long-term exposure to NO triggers mito-
chondrial biogenesis in mammalian cells and tissues through
the activation of guanylate cyclase and generation of cGMP.
The NO/cGMP-dependent mitochondrial biogenesis is asso-
ciated with enhanced coupled respiration and ATP content
in skeletal muscle (Nisoli et al., 2004). Nitric oxide induces
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mitochondrial biogenesis in skeletal myocytes through upregula-
tion of the peroxisome proliferator-activated receptor-γ coactiva-
tor 1α (PGC-1α) (Scarpulla, 2008). eNOS and nNOS are differen-
tially involved in the basal regulation of mitochondrial biogenesis
in skeletal muscle though Wadley et al. belives they are not criti-
cal for the exercise-induced increases inmitochondrial biogenesis
in this tissue (Wadley et al., 2007).The question on how criti-
cally NOS affects metabolic function in skeletal muscle remains
controversial. Nitric oxide interacts with the metabolic sensor
enzyme, AMPK (Lira et al., 2007). Nitric oxide and AMPK coop-
eratively regulate PGC-1α in skeletal muscle cells. The AMPKα1
isoform is identified as a mediator of NO-induced effects in
skeletal muscle cells. The authors propose a model of syner-
gistic interaction between AMPK and NOS for maintenance of
metabolic function in skeletal muscle (Lira et al., 2010). These
authors consider this interaction critical.
A phenotype of mice with quantitative reductions in eNOS
expression (approximately 40%) is characterized by reduced
expression of mitochondrial oxidative phosphorylation com-
plex, impaired ATP level, and increased total NOS activity and
CaMKII phosphorylation in skeletal muscle. A 30-min bout of
acute exercise in vivo elicits a number of physiological pro-
cesses that depend on eNOS expression with the exercise-induced
AMPKα phosphorylation being reduced in parallel with decrease
in eNOS expression. Ablation of eNOS results in impaired exer-
cise capacity, hypoglycemia, and increased plasma lactate levels
without changing the mitochondrial content (Lee-Young et al.,
2010). However, effects of NO are rarely unidirectional and ulti-
mately beneficial. Indeed, NO regulates mitochondrial oxygen
consumption through competitive binding to cytochrome-c oxi-
dase resulting in increased free radical content andmitochondrial
fragmentation.
NO exerts an inhibitory effect on the electron transport chain.
Low physiological NO concentration reversibly inhibits mito-
chondrial oxygen consumption by binding to a3-heme-site of
cytochrome oxidase in competition with oxygen. Increased NO
concentrations result in peroxinitrite production that, in turn,
irreversibly inhibits complex I and II of the electron trans-
port chain. Blood flow and oxygen consumption during exer-
cise can be regulated both at the level of the vasculature and
in the adjacent muscle mitochondria by similar parallel signals
(Boushel et al., 2012).
NOS inhibition potentiates mitochondrial respiration
(Boushel et al., 2012) as demonstrated in experiments where
L-NMMA was infused in femoral artery.
Characteristic property of NO is the ability to reversibly
and competitively inhibit cytochrome c oxidase, the terminal
enzyme of the mitochondrial respiratory chain (Bolaños et al.,
1994; Brown and Cooper, 1994; Cleeter et al., 1994). Inhibi-
tion of NOS is associated with increased oxygen consumption
in canine skeletal muscles at rest (Shen et al., 1994). Physiolog-
ical NO levels (about 20 nM) indeed affect oxygen consump-
tion in tissues (Thomas et al., 2004). The O2/NO ratio of about
500 is necessary to achieve 50%-inhibition of cytochrome c oxi-
dase (Boveris et al., 2000). Binding of NO to cytochrome c oxi-
dase triggers intracellular signaling events including diversion of
oxygen to non-respiratory substrates and ROS generation with
potentially hazardous consequences (Erusalimsky and Moncada,
2007). Considering that NO production by NOSs is oxygen-
dependent in normoxic tissues and is limited in hypoxia, nitrate-
nitrite-NO pathway is significantly facilitated and, therefore, can
complement NOS-based NO production in conditions that occur
during exercise or ischemia (van Faassen et al., 2009). Mitochon-
drial enzyme content and activity are increased in skeletal muscle
after the period of exercise (Little et al., 2011). Nitrates reduce
oxygen cost of exercise (Larsen et al., 2012).
Bailey et al., used 31P magnetic resonance spectroscopy
to evaluate metabolic abnormalities in skeletal muscle during
knee-extensor exercise in humans. Data showed that reduc-
tion in phosphocreatine concentration was attenuated and ATP
turnover rate was lower during exercise in the presence of dietary
nitrate supplementation compared with placebo (Bailey et al.,
2010). These results show that nitrate exerts its effects on the tar-
gets beyond mitochondria as well, presumably on the contractile
actin-myosin filaments or sarcoplasmic reticulum calcium load
(Larsen et al., 2012). Nitric oxide also stimulates mitochondrial
fragmentation, which can be caused by too much mitochondrial
fission or mitochondrial fusion inhibition causing bioenergetic
failure (Knott and Bossy-Wetzel, 2010).
eNOS expression, mitochondrial biogenesis, mitochondrial
volume density and number, and both basal and insulin-
stimulated levels of glucose uptake are increased in the left ventri-
cle of wild type mice subjected to swimming exercise. In contrast,
genetic deletion of eNOS prevents all these adaptive phenomena
(Vettor et al., 2014).
This evidence suggests that mitochondria may represent a
target for NO that is released during exercise.
Myokines and NO-Mediated Signaling
Myokines comprise cytokines and other molecules that are
expressed and released by muscle fibers and exert autocrine,
paracrine and/or endocrine effects. Hundreds of myokines have
been identified, but information regarding myokine-dependent
regulation triggered by contraction and other stimuli is lacking in
most cases (Eckardt et al., 2014). There is lack of data about puta-
tive interplay between NO-mediated signaling and myokines.
However, sparse evidence suggests that such interplay can in fact
exist (Takahashi et al., 1999; Figueras et al., 2004; Steensberg et al.,
2007; Ouchi et al., 2008; Murata et al., 2012; Sandonà et al., 2012;
Baum et al., 2013; Most et al., 2013; Chong et al., 2014).
For example, studies demonstrate interplay between inter-
leukin myokines and NO-signaling (Takahashi et al., 1999;
Steensberg et al., 2007; Murata et al., 2012; Chong et al., 2014).
Steensberg with coworkers hypothesized that exercise-induced
NO production is an important signaling event for expres-
sion of myokines IL-6 and IL-8 in the muscle. L-NAME causes
significant reductions in the exercise-induced mRNAs expres-
sion of these myokines. Nitroglycerin infusion significantly aug-
ments expression of mRNAs attenuated by L-NAME. These
findings confirm an idea that NO production is involved in
the regulation of myokine gene expression in muscle during
exercise (Steensberg et al., 2007). Association between nitrite
and myokine IL-6 levels is shown in crush syndrome (CS)
caused by muscle compression of the limb with subsequent
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reperfusion. Tissue nitrite level in injured muscles is significantly
reduced in the CS group compared with the sham group during
ischemia/reperfusion injury. Nitrite administration to CS ani-
mals restores NO bioavailability by enhancing nitrite levels in
the muscle, causing a reduction of rhabdomyolysis markers such
as potassium, lactate dehydrogenase, and creatine phosphoki-
nase. Nitrite treatment also reduces plasma levels of IL-6 and
myeloperoxidase activities in the muscle and lung tissues. Murata
with coauthors reported the therapeutic effects of nitrite in CS
(Murata et al., 2012). IL-13 prevents the deterioration of con-
traction induced by endotoxin through inhibition of NO produc-
tion mainly in the type I muscle fibers in a septic animal model
(Takahashi et al., 1999). In skeletal muscle of tumor-bearing ani-
mals, administration of myokine IL-15 modulates apoptosis and
decreases iNOS protein expression by 73%, suggesting that NO
formation and muscle apoptosis may be related. IL-15 seems to
reduce or suppress protein loss and apoptosis associated with
muscle wasting in experimental model (Figueras et al., 2004).
In non-muscular tissue, myokine protein, angiopoietin-like 4
(ANGPTL4), accelerates wound healing. Exogenous ANGPTL4
modulates several regulatory networks involved in the cell migra-
tion, angiogenesis, and inflammation. Signaling pathways involv-
ing ANGPTL4 are not clear, but, in wound epithelia, ANGPTL4
induces NO production through upregulation of iNOS expres-
sion (Chong et al., 2014). Ouchi with coworkers investigated the
role of Follistatin-like 1 (Fstl1) in the regulation of endothe-
lial cell function and blood vessel growth in the muscle. Fstl1
is a myokine that promotes endothelial cell function. It stim-
ulates ischemia-triggered revascularization though the activa-
tion of Akt-eNOS signaling. Increased expression of Akt1 in
skeletal muscle increases muscle capillary density, myofiber
growth, Fstl1 induction, and flow recovery associated with
an increase in eNOS phosphorylation in the ischemic hind
limbs of wild-type mice. The stimulatory effect of Ad-Fstl1 on
ischemic limb reperfusion is abolished in mice lacking eNOS
(Ouchi et al., 2008).
Animals subjected to skeletal muscle ischemia/reperfusion
have significantly lower NO levels in muscle tissue when admin-
istered with intravenous myokine vascular endothelial growth
factor (VEGF) compared with control animals subjected only
to ischemia/reperfusion (Kirisci et al., 2013). The mRNA lev-
els of VEGF-A are lower in the muscle of nNOS-knockout
mice compared with the wild-type littermates (Baum et al.,
2013). Unresolved ischemia entails excessive VEGF accumula-
tion with aggravated VEGF receptor-2 degradation and blunted
in vivo signaling through the proangiogenic phosphoinositide-3-
kinase/Akt/eNOS cascade in mice (Most et al., 2013).
More research is needed to identify detailed mechanisms of
the interactions between NO-mediated signaling and myokines
in skeletal muscle during physical exercise.
Nitric Oxide is an Important Factor in Therapeutic
Effects of Physical Activity in Various Diseases
Physical activity is currently considered as an important ther-
apeutic factor in various diseases. To successfully combine the
benefits of exercise with pharmacotherapeutic approaches, one
must have a clear understanding of how exercise affects patient’s
body. Treatment of diabetes is one of the best examples in this
regard.
Physical Exercise and NO in Diabetes Mellitus
On one hand, the presence of glucose tolerance in diabetic skele-
tal muscle raises concerns about relevance of physical exercise
for correction of diabetes symptoms. However, both experimen-
tal and clinical data suggest that beneficial effects of exercise
are directly associated with NO production. The course of 40-
min exercise 3 days per week for 12 weeks results in decreased
plasma concentrations of NO and endothelin 1 in patients with
impaired glucose tolerance (Kasimay et al., 2010). It may be that
the decrease in endothelin 1 plays a primary role in mediating
beneficial effects of exercise in this case as NO does not directly
affect glucose utilization.
In rats with type 1 diabetes mellitus, eNOS protein expres-
sion increases in sedentary lifestyle and further increases when
animals are subjected to exercise. The authors conclude that exer-
cise alleviates impaired eNOS- and nNOS-dependent arteriolar
responses in type 1 diabetes mellitus without changing nNOS
in brain tissue (Mayhan et al., 2011). In diabetic rats, exercise
training attenuates subcortical infarct volume after ischemia-
reperfusion of the middle cerebral artery (Arrick et al., 2012).
The endurance training in rats with type 1 diabetes mellitus is
more effective than resistance training. It improves acetylcholine-
induced vasorelaxation responsiveness (Murias et al., 2013).
The study by Rodrigues with coworkers showed that exer-
cise improves glycemic control, increases NO bioavailability, bet-
ter controls oxidative stress, and corrects renal function. In this
study, diabetic nephropathy was simulated in Wistar rats sub-
jected to 8-week treadmill training with a work rate of 16 m/min,
60min/d for 5 days per week. Diabetic animals had reduced
creatinine and urea clearance and NO excretion and increased
blood glucose concentrations, albuminuria, and excretion of the
thiobarbituric acid reactive substances compared with control
(Rodrigues et al., 2011). Additionally, 3- to 4-week exercise train-
ing corrected erectile dysfunction caused by central administra-
tion of exogenous NO donor, sodium nitroprusside, in rats with
type 1 diabetes mellitus (Rodrigues et al., 2011; Zheng et al.,
2011).
Type 2 diabetic patients have elevated levels of systemic
free radicals severely restricting the endothelial NO bioavailabil-
ity and contributing to endothelial dysfunction. Physical exer-
cise enhances NO synthesis in blood vessels through increases
in eNOS availability and activity (Brinkmann et al., 2011). In
patients with type 2 diabetes, 6-week training (90-min exercises 4
times per week) partially restores NOS activity in the erythrocytes
(Ladage et al., 2012).
Functional evaluation of the isolated aortic rings showed
that exercise training restores acetylcholine-induces endothelial-
dependent vasodilation in mice with type 2 diabetes mellitus
without increasing eNOS protein expression. This improvement
is associated with an activation of the adiponectin-dependent and
independent pathways (Lee et al., 2011; Cordani et al., 2014).
Overall, many authors have reported changes in NOS activ-
ity in diabetes. However, only a few of them attempted to study
therapeutic modulation of NO production in this condition.
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Physical Exercise in Cardiovascular Diseases
12-week course of Tai Chi exercise results in an increase of NO
content in blood plasma of patients with essential hypertension.
This effect is not observed in the control group of healthy vol-
unteers and untrained hypertonic patients (Pan et al., 2014).
The experiments in laboratory animals show that 5-week train-
ing improves myocardial antioxidant capacity, prevents excessive
NO synthesis, and limits formation of cytotoxic peroxynitrite in
the reaction between NO and O2 (Farah et al., 2013).
Both aerobic and resistance training increases peak oxygen,
improves cardiac function, reduces mortality, and enhances per-
formance and the quality of life in patients with chronic heart
failure. These improvements occur due to the effects of train-
ing on the peripheral circulation and skeletal muscle, rather than
on the heart itself. Exercise training and effort promotes the
synthesis and release of nitric oxide, decreases oxidative stress,
increases blood flow in active skeletal muscle, improves skeletal
muscle metabolism, improves angiogenesis, reduces sympathetic
arousal, and increases parasympathetic arousal that alleviates
cardiac dysrythmia and ischemia (Ga˛siorowski and Dutkiewicz,
2013).
Chronic heart failure interferes with NO-mediated regulation
of oxygen delivery-utilization matching such that microvascu-
lar oxygenation falls faster in response to increases in metabolic
demand in skeletal muscle. Physical exercise training improves
kinetics of oxygen partial pressure by NO-dependent mecha-
nisms in microvessels after muscle contractions in healthy young
individuals. The model of murine chronic heart failure shows
that there are two pathways that improve oxygenation in skeletal
muscle microvessels and one of them is NO-mediated (Hirai
et al., 2014).
Nitric Oxide in Skeletal Muscle Diseases
Abnormal NO-signaling occurs in degenerative muscle diseases
including muscular atrophies and dystrophies (Wang and Lu,
2013).
There is evidence that oxidative stress causes nNOSµ relo-
cation from the sarcolemma as well as dephosphorylation of
FOXO3a transcription factor as an early event during the
mechanical unloading. The redox signaling serves here as a sig-
nal for nNOS to change morphology of skeletal muscle fibers.
This was proven by using EUK-134, a cell-permeable mimetic of
superoxide dismutase and catalase. This agent enabled examina-
tion of the redox signaling in nNOSµ translocation and atrophy
of muscle fibers upon short-term (54 h) limb unloading (Lawler
et al., 2014). Interestingly, terrestrial gravity force may play an
effect in the regulation of NOS relocation. For instance, the effect
of microgravity on skeletal muscle was examined in rat and mice
after short-term (5–20 days) spaceflights. Spaceflight induces
translocation of sarcolemmal nitric oxide synthase-1 (NOS1) into
the cytosol in soleus but not in the fast-twitch extensor digitorum
longus muscle (Sandonà et al., 2012).
In Duchenne muscular dystrophy (DMD) patients and
murine mdx model of DMD, dystrophin deficiency causes
a decrease in muscle and mislocalization of muscle spe-
cific isoform nNOSµ leading to dysfunction. Systematic
FIGURE 1 | Interplay between exercise, NO production, and signaling pathways in skeletal muscle.
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study of Uaesoontrachoon et al. demonstrates the effects of a
NO-donating naproxen derivative, naproxcinod, on skeletal and
cardiac disease phenotype in mdx mice subjected to treadmill
sessions twice weekly with functional and behavioral assessments
at 3, 6, and 9 months of treatment. Naproxcinod treatment sig-
nificantly improves hind limb grip strength and results in less
inflammation (Uaesoontrachoon et al., 2014).
These data may suggest that NO, whose production is
increased during physical exercise through various pathways, is
involved in the correction of functional disorders. This occurs
rather through modulation of vascular function than through a
direct impact on glucose utilization by skeletal myocytes. Cardio-
vascular patients greatly benefit from the administration of mod-
erate physical exercise. We hypothesize that therapeutic effects
of physical training can be associated with NO production. In
available literature, there is lack of direct evidence in favor of
this hypothesis. However, there is plenty of indirect data sup-
porting this idea. Though it remains an open question, we would
like to present this hypothesis to stimulate further studies and
discussion.
Conclusions
Nitric oxide production is intrinsically associated with physi-
cal activity. Enhanced NO release in physical exercise is medi-
ated through eNOS gene transcription. Effects of NO release on
muscle activity are mostly beneficial and occur through various
signaling pathways (Figure 1). The mechanisms comprise well-
known abilities of NO to cause vasodilation (Black et al., 2008),
enhance regional blood flow/microcirculation, and to modulate
hormone-dependent energy supply of muscle contraction. At the
same time, NO directly affects myocytes and increases energy
production in the mitochondria. Scarce data suggest the presence
of the associations between NO- and myokine-dependent signal-
ing mechanisms exerting various beneficial physiological effects.
However, these effects of NO are limited and, in certain situa-
tions, can turn into the opposite leading to free radical accumu-
lation and mitochondrial fragmentation. Evidence confirms an
important role of NO in various diseases. Indeed, diabetes is asso-
ciated with an increase in eNOS expression upregulated during
exercise. In patients with chronic heart failure, beneficial effects of
physical training are caused by impact of NO on the skeletal mus-
cle energy metabolism associated with NO production (Okutsu
et al., 2014). There is a positive feedback between NO-dependent
production of certain myokines and angiogenesis that occurs in
the presence of ischemia. Beneficial effects of NO are documented
in degenerative muscle diseases. Nitric oxide-mediated signaling
pathway clearly represents a promising target for a treatment of
a variety of diseases and for achievement of better athletic per-
formance. All in all, skeletal muscle produces plenty of bioactive
substances including NOwhich plays a key role in a readjustment
of all autonomic systems of the organism during exercise.
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